Table 2 Cross-study comparison of three- and 12 month landmark events (Major Bleeding and Thromboembolism)
EVENTS (Cumulative Incidence) | CONKO-04 | FRAGEM | SC-IDPTP |
|---|---|---|---|
Major Bleed (3 Months) | 4.5%(7/160) | 3%(3/59) | 2.4% (2/82) |
Major Bleed (12 months) | 8.3%(13/160) | Not Reported (N/R) | 9.7% (8/82) |
Breakthrough PE/DVT (12 months) | 5.7%(9/160) | a8.4% (5/59) | b4.8% (4/82) |
Breakthrough All type TE (12 months) | Not Reported (N/R) | 12% (7/59) | 8.5% (7/82) |